Results 261 to 270 of about 46,488 (301)

Intermediate density lipoprotein cholesterol as the best lipoprotein predictor of atherosclerosis severity in the Watanabe Heritable Hyperlipidemic rabbit

Atherosclerosis, 1997
a Department of Clinical Biochemistry, Rigshospitalet, Uni6ersity of Copenhagen, Copenhagen, Denmark b Department of Clinical Biochemistry, Herle6 Hospital, Uni6ersity of Copenhagen, Herle6 Ring6ej 75, DK-2730 Herle6, Denmark c Department of Pathology, H6ido6re Hospital, Uni6ersity of Copenhagen, Copenhagen, Denmark d Department of Cardiology, H6ido6re
Birgit Fischer Hansen, Birgit Agerholm-Larsen, Alicja Mortensen, P H Ibsen, Jørgen Fischer Hansen, Knud Kjeldsen, Børge G. Nordestgaard   +6 more
openaire   +3 more sources

The metabolism of very low density and intermediate density lipoproteins in patients with familial hypercholesterolaemia

Atherosclerosis, 1982
The metabolism of apolipoprotein B (apoB) in very low density lipoprotein (VLDL) and intermediate density lipoprotein (IDL) was studied in normal subjects and in patients with familial hypercholesterolaemia (FH) after an intravenous injection of autologous VLDL labelled with 125I.
Gilbert R. Thompson, Nicolas B. Myant, Anne K. Soutar   +2 more
openaire   +3 more sources

Intermediate-density lipoproteins, diabetes and coronary artery disease

Diabetes Research and Clinical Practice, 1998
The results of various studies suggest that hypertriglyceridaemia is associated with an increased risk of coronary artery disease. It is unclear, however, which particular triglyceride (TG)-rich lipoproteins contribute to the risk. Different types of TG-rich lipoprotein differ in function, composition, size and density.
openaire   +3 more sources

Fractionation of cholesteryl ester rich intermediate density lipoprotein subpopulations by chondroitin sulphate

Atherosclerosis, 2007
IDL is considered an atherogenic lipoprotein but little progress has been made on methods to subfractionate this density class. Furthermore, previous work suggests that lipoproteins retained by the arterial wall, of which chondoitin sulphate is the major arterial wall proteoglycan, are potentially atherogenic.
Barbara J. Meyer, Barbara J. Meyer, Laurence Duvillard, Alice J. Owen, Muriel J. Caslake, Chris J. Packard   +5 more
openaire   +4 more sources

Intermediate-Density Lipoproteins and Progression of Carotid Arterial Wall Intima-Media Thickness

Circulation, 1997
Background Although LDL cholesterol (LDL-C) is generally accepted to be a major risk factor for progression of atherosclerosis, the traditional measurement of LDL-C includes measurement of IDL. Little is known about the relationship between IDL and progression of atherosclerosis.
Meleana E. Dunn, Chao-ran Liu, Ci-hua Liu, Robert H. Selzer, Howard N. Hodis, Ronald M. Krauss, Wendy J. Mack   +6 more
openaire   +3 more sources

Physical training and plasma intermediate density lipoprotein cholesterol levels in men with hypertriglyceridemia

Biochemical Medicine and Metabolic Biology, 1986
Plasma lipoprotein lipid levels including IDL cholesterol concentration, physical fitness parameters, and anthropometric data were measured in 10 men with primary hypertriglyceridemia during a 12 week program of moderate physical training. Reduced pulse rate at submaximal workload and increased work performed on the treadmill indicated that the men had
Wayne H.F. Sutherland, Edwin R. Nye, M. C. Robertson, B.C. Grant, R.B. Stenning   +4 more
openaire   +3 more sources

Two subpopulations of intermediate density lipoprotein and their relationship to plasma triglyceride and cholesterol levels

Atherosclerosis, 2000
We observed the appearance of two intermediate density lipoprotein (IDL) subfractions on gradient gel electrophoresis of lipoproteins in the density range 1.006-1.030 g/ml and estimated their approximate concentrations in plasma in subjects with a wide range of lipid levels, from 0.55 to 28.0 mmol/l plasma triglyceride and 3.75-10.0 mmol/l cholesterol.
Muriel J. Caslake, Christopher J. Packard, Barbara J. Meyer, M. McConnell   +3 more
openaire   +3 more sources

Effect of fluvastatin on intermediatedensity Lipoprotein (remnants) and other lipoprotein levels in hypercholestarolemia

The American Journal of Cardiology, 1995
The accelerated atherosclerosis in diseases associated with elevated remnant lipoprotein levels has directed interest toward the response of this lipoprotein species to lipid-lowering treatment. The effect of fluvastatin--a synthetic 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitor--was compared with that of placebo on parameters of ...
Donald B. Hunninghake, Robert H. Knopp, Frances E. Broyles, Deborah Hill-Williams, Carolyn E. Walden   +4 more
openaire   +3 more sources

Thyroxine inversely regulates serum intermediate density lipoprotein levels in children with congenital hypothyroidism

Pediatrics International, 1999
Although there have been numerous studies on the effects of thyroid hormones on serum lipid profiles, the effects of thyroxine on intermediate how density lipoprotein (IDL) remain uncertain. In an attempt to clarify, this issue, under conditions with very little influence exerted by sex hormones on serum lipid profiles, we studied the relationship ...
Tatiana Ciomartan, Tadashi Asami, Makoto Uchiyama   +2 more
openaire   +3 more sources

Analysis of the selective uptake of the cholesteryl ester of human intermediate density lipoproteins by HepG2 cells

Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1994
We have recently shown by the analysis of the association to HepG2 cells of human intermediate density lipoproteins (IDL) either labeled in cholesteryl ester (CE) with [3H]cholesteryl ethers (CEt) or in proteins by iodine-125 that the CE of IDL are selectively taken up by these cells. Our results also revealed that the addition of a sufficient quantity
Louise Falstrault, Louise Brissette
openaire   +3 more sources